Coleen Glessner
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Coleen Glessner is currently Executive VP-Quality, Ethics & Compliance at Emergent BioSolutions, Inc. since 2020.
Formerly, Ms. Glessner was Chief Quality Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. from 2017 to 2021 and also served as VP, Head-R&D Quality at Alexion Pharmaceuticals,.
Inc. Education includes an undergraduate degree from the University of Pittsburgh and an MBA from the Massachusetts Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-06-2026 | 202.201 ( 0,39% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Compliance Officer | 01-03-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau